Results 71 to 80 of about 96,603 (330)

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

Neurourology and Urodynamics, EarlyView.
ABSTRACT Purpose Vibegron was associated with improvements in efficacy versus placebo and was well tolerated in men with overactive bladder (OAB) on pharmacotherapy for benign prostatic hyperplasia (BPH) in the COURAGE trial (NCT03902080). Additional safety, bladder function, and urodynamics data are provided.
Eric S. Rovner, Janet Owens‐Grillo, Elizabeth Thomas, Sender Herschorn, Kenneth M. Peters, David Staskin, Salim Mujais   +6 more
wiley   +1 more source

Recanalization of prostatic artery chronic total occlusion prior to prostatic artery embolization

Radiology Case Reports, 2019
Urinary obstruction secondary to benign prostatic hyperplasia is a late manifestation of the disease, and a poor prognostic sign for responding to conservative therapies.
Adam N. Plotnik, MBBS MSc MMed FRANZCR EBIR, Dustin G. Roberts, BS, Ravi N. Srinivasa, MD, Justin P. McWilliams, MD   +3 more
doaj   +1 more source

Periacinar clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma [PDF]

, 2006
The aim of the present study was to correlate the presence and extent of retraction clefting and the expression of p63 in neoplastic glands and glands with prostatic intraepithelial neoplasia (PIN) in needle core biopsies.
Belicza, Mladen, Cviko, Aida, Krušlin, Božo, Odak, Ljubica, Tomas, Davor, Čupić, Hrvoje   +5 more
core   +1 more source

Impact of COVID‐19 and Vaccination on Lower Urinary Tract Symptoms: Insights From a Prospective Cohort Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza, Jose de Bessa Jr., Natássia Cristina Carboni Truzzi, Carolina Trigo Rocha, Bruno Camargo Rocha Paim de Araujo, Julyana Kanate Mazzoni Moromizato, Thulio Bosi Vieira Brandão, Rachel Mazoni Costa, Marcelo Hisano, Zein Mohamed Sammour, Homero Bruschini, William Carlos Nahas, Cristiano Mendes Gomes   +12 more
wiley   +1 more source

Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia

The Egyptian Journal of Radiology and Nuclear Medicine, 2016
Objectives: To assess the feasibility and efficacy of prostatic artery embolization in relieving symptoms of benign prostatic hyperplasia. Materials and methods: In a prospective study 28 patients with symptomatic benign prostatic hyperplasia were ...
Mohamed Shaker, Karim A. Abd El Tawab, Khaled H. Abd El Tawab, Mohamed El-Gharib   +3 more
doaj   +1 more source

Decision‐Making Process of Healthcare Providers Regarding Catheterization Method: A Nationwide Survey Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Background The decision on which catheterization method to prescribe should be made on an individual basis, considering each patient's individual needs and circumstances. However, the current decision‐making process regarding assisted bladder drainage might not be transparent or standardized.
Coen Huibert Harry Christiaans, Felice Emanuela Espèrance van Veen, Jeroen Ronald Scheepe, Bertil Freddo Maarten Blok   +3 more
wiley   +1 more source

Successful treatment of complicated benign prostatic hyperplasia in a diabetic patient with water vapor thermal therapy and urethral stenting

Urology Case Reports, 2019
Water Vapor Thermal Therapy is a novel, office-based procedure which has gained traction as first line therapy in specific therapeutic cases of benign prostatic hyperplasia.
Tej J. Desai, Jared J. Wallen
doaj   +1 more source

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)

Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya, 2020
Benign prostatic hyperplasia (BPH) is one of the most common benign tumors in men with prevalence ranging from 50% for men in their 60s to 90% for men in their 80s.
Aulia Nur Fadila, Anny Setijo Rahaju, Tarmono Tarmono   +2 more
doaj   +1 more source

Holmium Laser Enucleation of the Prostate [PDF]

, 2018
Introduction: Holmium laser enucleation of the prostate (HoLEP) offers superior voiding outcomes to traditional transurethral resection and less morbidity than open simple prostatectomy. Likewise, HoLEP has been determined to result in excellent outcomes
Krambeck, Amy E., Lingeman, James E., Rivera, Marcelino E.   +2 more
core   +1 more source

Benign Prostatic Hyperplasia and Prostate Cancer [PDF]

Epidemiologic Reviews, 2001
This paper reviews the epidemiologic studies of benign prostatic hyperplasia in relation to prostate cancer. Such relation was investigated in epidemiologic studies but none have provided clear evidence suggesting an etiologic role for benign prostatic hyperplasia in the development of prostatic cancer.
openaire   +2 more sources